ClinicalTrials.Veeva

Menu

Chlorhexidine & Pneumonia in Nursing Home Residents

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status and phase

Completed
Phase 1

Conditions

Pneumonia
Respiratory Infection

Treatments

Drug: Placebo mouthwash
Drug: chlorhexidine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00841074
DE015760
OGMB040944

Details and patient eligibility

About

The purpose of this study is determine if topical oral application of a chlorhexidine antimicrobial spray will significantly reduce pneumonia and respiratory infections, and improve oral health compared to a placebo solution in nursing home residents.

Enrollment

75 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Participants must be at least 65 years old.
  2. Be dependent in 2 or more Activities of Daily Living as noted on the nursing home resident's Minimum Data Set - One must be ADL J- Personal Hygiene.
  3. Have natural teeth and/or wear complete or partial dentures.
  4. Expected to be a resident in a nursing home for two years.

Exclusion criteria

  1. Existing pneumonia.
  2. History of chlorhexidine reaction or allergy and/or multiple medication or substance allergies.
  3. Receiving chlorhexidine oral application at enrollment as prescribed by physician or dentist.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

75 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
Peridex mouthwash
Treatment:
Drug: chlorhexidine
2
Placebo Comparator group
Description:
Placebo mouthwash
Treatment:
Drug: Placebo mouthwash

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems